|
Name |
3-tert-Butylphenol
|
Molecular Formula | C10H14O | |
IUPAC Name* |
3-tert-butylphenol
|
|
SMILES |
CC(C)(C)C1=CC(=CC=C1)O
|
|
InChI |
InChI=1S/C10H14O/c1-10(2,3)8-5-4-6-9(11)7-8/h4-7,11H,1-3H3
|
|
InChIKey |
CYEKUDPFXBLGHH-UHFFFAOYSA-N
|
|
Synonyms |
3-tert-Butylphenol; 585-34-2; m-tert-Butylphenol; 3-(tert-butyl)phenol; Phenol, 3-(1,1-dimethylethyl)-; 3-t-Butylphenol; 3-tert-butyl-phenol; Phenol, m-tert-butyl-; CHEBI:34348; 2382U55WN2; MFCD00002300; UNII-2382U55WN2; 3-tertbutylphenol; 3-tert.butylphenol; EINECS 209-553-4; m-tert.-butylphenol; 3-tert.-butylphenol; meta-tert-butylphenol; 3-tert-Butyl phenol; 3-tert-Butylphenol;; Phenol, 3-tert-butyl-; ST50824235; 3-tert-butyl-hydroxybenzene; 3-tert-Butylphenol, 99%; DSSTox_CID_24825; DSSTox_RID_80506; DSSTox_GSID_44825; SCHEMBL50933; BIDD:ER0561; CHEMBL224899; 3-(1,1-dimethylethyl)-phenol; DTXSID9044825; CYEKUDPFXBLGHH-UHFFFAOYSA-; ZINC2012740; Tox21_301686; 3-(1,1-DIMETHYLETHYL)PHENOL; 5-TERT-BUTYL-1-HYDROXYBENZENE; AKOS000120521; NCGC00256058-01; AC-26474; AS-14546; CAS-585-34-2; B0731; CS-0015724; FT-0616395; EN300-20961; O11053; A831909; AE-562/43460593; Q-200396; Q27116004
|
|
CAS | 585-34-2 | |
PubChem CID | 11450 | |
ChEMBL ID | CHEMBL224899 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 150.22 | ALogp: | 3.3 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.6 |
Caco-2 Permeability: | -4.557 | MDCK Permeability: | 0.00002120 |
Pgp-inhibitor: | 0.025 | Pgp-substrate: | 0.018 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.503 |
30% Bioavailability (F30%): | 0.64 |
Blood-Brain-Barrier Penetration (BBB): | 0.47 | Plasma Protein Binding (PPB): | 90.78% |
Volume Distribution (VD): | 3.412 | Fu: | 13.56% |
CYP1A2-inhibitor: | 0.965 | CYP1A2-substrate: | 0.841 |
CYP2C19-inhibitor: | 0.823 | CYP2C19-substrate: | 0.619 |
CYP2C9-inhibitor: | 0.529 | CYP2C9-substrate: | 0.895 |
CYP2D6-inhibitor: | 0.807 | CYP2D6-substrate: | 0.723 |
CYP3A4-inhibitor: | 0.176 | CYP3A4-substrate: | 0.37 |
Clearance (CL): | 11.363 | Half-life (T1/2): | 0.763 |
hERG Blockers: | 0.03 | Human Hepatotoxicity (H-HT): | 0.052 |
Drug-inuced Liver Injury (DILI): | 0.029 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.33 | Maximum Recommended Daily Dose: | 0.248 |
Skin Sensitization: | 0.817 | Carcinogencity: | 0.063 |
Eye Corrosion: | 0.981 | Eye Irritation: | 0.991 |
Respiratory Toxicity: | 0.363 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000898 | 0.548 | D0S5LH | 0.452 | ||||
ENC000500 | 0.500 | D06YPU | 0.388 | ||||
ENC000185 | 0.457 | D04EYC | 0.386 | ||||
ENC000744 | 0.457 | D0O6IU | 0.378 | ||||
ENC005113 | 0.457 | D0K4MH | 0.358 | ||||
ENC000695 | 0.426 | D0X4ZR | 0.340 | ||||
ENC000003 | 0.421 | D0S5YC | 0.305 | ||||
ENC000152 | 0.419 | D0K5CB | 0.298 | ||||
ENC001049 | 0.400 | D02ZJI | 0.298 | ||||
ENC000611 | 0.396 | D0G1OZ | 0.292 |